Convergent Genomics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
425 Eccles Ave Fl 2, South San Francisco...Phone Number
(415) 839-0077Website
www.convergentgenomics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Convergent Genomics
Convergent Genomics is a genomic diagnostic company focused on simplifying and accelerating cancer diagnostics through personalized data and actionable insights. They offer a non-invasive test called UroAmp, which utilizes urine DNA analysis to detect bladder cancer much earlier than traditional methods. Their solutions are aimed at clinicians and patients, providing robust clinical data and improving cancer care outcomes. Founded by a multidisciplinary team, the company aims to change the way cancer is diagnosed, monitored, and managed.Explore more
Convergent Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Convergent Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Convergent Genomics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Convergent Genomics has new funding data
Convergent Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Convergent Genomics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Convergent Genomics
Check out if Convergent Genomics is spiking on competitors!
Product Launch: Get notified when Convergent Genomics launches new products
Check if Convergent Genomics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Convergent Genomics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Convergent Genomics
Compare insights from companies similar to Convergent Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Convergent Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Convergent Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Convergent Genomics.
Convergent Genomics Tech Stack
A closer look at the technologies used by Convergent Genomics
Convergent Genomics News & Media
Genomic Urine Test Detects Bladder Cancer from DNA Up to 12 Years Before Clinical Signs and Symptoms Appear
Advances in Next-Generation DNA Sequencing and Machine Learning Enable Rapid Analysis of Genetic Mutations to Determine Cancer Risk CHICAGO, May 1, 2023 /PRNewswire/ -- A new genomic urine test can help doctors accurately predict bladder cancer as many as 12 years before clinical signs...New Studies on Convergent Genomics' Urine Test for Bladder Cancer to be Presented at 2023 American Urological Association (AUA) Annual Meeting
CHICAGO, April 25, 2023 /PRNewswire/ -- Convergent Genomics announced UroAmp, the company's genomic urine test that uses next-generation DNA sequencing and machine learning to detect and monitor for bladder cancer, will be the subject of two new studies being presented at the 2023...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Convergent Genomics
Sign Up For FreeTo access detailed company insights
Convergent Genomics is a genomic diagnostic company focused on simplifying and accelerating cancer diagnostics through personalized data and actionable insights. They offer a non-invasive test called UroAmp, which utilizes urine DNA analysis to detect bladder cancer much earlier than traditional methods. Their solutions are aimed at clinicians and... Read More
